Science & Tech · AI · 3 hrs ago
XtalPi expands Singapore partnership to develop new materials
Chinese AI drug firm XtalPi has expanded a partnership in Singapore.
The work is part of a program called MARVEL-AI.
The companies plan to develop new materials through the partnership.
They will use computational tools and automated laboratory experiments.
These methods combine computer-based work with lab testing.
The partnership aims to create materials using both approaches.
The announcement does not say which materials will be developed or when the work will be completed.
XtalPi is expanding a partnership in Singapore to develop new materials.
The work will take place under the MARVEL-AI program.
The companies will use computational tools and automated laboratory experiments.
The article does not name XtalPi’s partner or give a timeline for the work.
- Who
- XtalPi and an unnamed partner.
- What
- They will develop new materials using computational tools and automated laboratory experiments.
- When
- The article was published on October 30, 2026; the work’s start date is not stated.
- Where
- Singapore.
- Why
- Not stated.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Company
- XtalPi
- Location
- Singapore
- Program
- MARVEL-AI
- Methods
- Computational tools and automated laboratory experiments